Literature DB >> 19267186

Postprandial changes in solubilizing capacity of human intestinal fluids for BCS class II drugs.

Sarah Clarysse1, Dimitrios Psachoulias, Joachim Brouwers, Jan Tack, Pieter Annaert, Guus Duchateau, Christos Reppas, Patrick Augustijns.   

Abstract

PURPOSE: To explore the effect of the nutritional state on the solubilizing properties of human intestinal fluids (HIF) on a time-after-food administration basis.
METHODS: HIF were collected in fractions of 30 min from five volunteers in the fasted, fed and fat-enriched fed state. In vitro solubility of five BCS class II drugs (danazol, diazepam, nifedipine, ketoconazole, indomethacin) was assessed in the intestinal fractions and simulated intestinal fluids.
RESULTS: Solubilities in intestinal fractions were characterized by high time- and subject-dependent variability. For the non-ionized drugs, solubility in early intestinal fractions was higher in both fed states compared to the fasted state, and in the fat-enriched fed state compared to the fed state. Solubility in simulated intestinal fluids did not sufficiently predict the solubilizing capacity of the early postprandial phase. Solubility in HIF was shown to be determined by a complex interplay of various intraluminal parameters. For the ionized drugs, pH played a significant role for indomethacin (R (2) = 0.86); for the partly ionized ketoconazole other intraluminal parameters were also important.
CONCLUSIONS: Solubilizing capacity of HIF in the fed state is strongly time-dependent. Intraluminal dissolution may, therefore, vary with drug arrival time in the small intestine and constitute a source of variability in intestinal drug absorption.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19267186     DOI: 10.1007/s11095-009-9857-7

Source DB:  PubMed          Journal:  Pharm Res        ISSN: 0724-8741            Impact factor:   4.200


  23 in total

1.  Intraluminal drug and formulation behavior and integration in in vitro permeability estimation: a case study with amprenavir.

Authors:  Joachim Brouwers; Jan Tack; Frank Lammert; Patrick Augustijns
Journal:  J Pharm Sci       Date:  2006-02       Impact factor: 3.534

2.  Characterization of the human upper gastrointestinal contents under conditions simulating bioavailability/bioequivalence studies.

Authors:  Lida Kalantzi; Konstantinos Goumas; Vasilios Kalioras; Bertil Abrahamsson; Jennifer B Dressman; Christos Reppas
Journal:  Pharm Res       Date:  2006-12-01       Impact factor: 4.200

3.  Separation and characterization of the colloidal phases produced on digestion of common formulation lipids and assessment of their impact on the apparent solubility of selected poorly water-soluble drugs.

Authors:  Greg A Kossena; Ben J Boyd; Christopher J H Porter; William N Charman
Journal:  J Pharm Sci       Date:  2003-03       Impact factor: 3.534

4.  Canine intestinal contents vs. simulated media for the assessment of solubility of two weak bases in the human small intestinal contents.

Authors:  Lida Kalantzi; Eva Persson; Britta Polentarutti; Bertil Abrahamsson; Konstantinos Goumas; Jennifer B Dressman; Christos Reppas
Journal:  Pharm Res       Date:  2006-05-25       Impact factor: 4.200

Review 5.  Lipids and lipid-based formulations: optimizing the oral delivery of lipophilic drugs.

Authors:  Christopher J H Porter; Natalie L Trevaskis; William N Charman
Journal:  Nat Rev Drug Discov       Date:  2007-03       Impact factor: 84.694

6.  Estimation of the increase in solubility of drugs as a function of bile salt concentration.

Authors:  S D Mithani; V Bakatselou; C N TenHoor; J B Dressman
Journal:  Pharm Res       Date:  1996-01       Impact factor: 4.200

7.  Solubilisation of poorly water-soluble drugs during in vitro lipolysis of medium- and long-chain triacylglycerols.

Authors:  Janne Ørskov Christensen; Kirsten Schultz; Birgitte Mollgaard; Henning Gjelstrup Kristensen; Anette Mullertz
Journal:  Eur J Pharm Sci       Date:  2004-11       Impact factor: 4.384

8.  Solubilization and wetting effects of bile salts on the dissolution of steroids.

Authors:  V Bakatselou; R C Oppenheim; J B Dressman
Journal:  Pharm Res       Date:  1991-12       Impact factor: 4.200

9.  Postprandial evolution in composition and characteristics of human duodenal fluids in different nutritional states.

Authors:  S Clarysse; J Tack; F Lammert; G Duchateau; C Reppas; P Augustijns
Journal:  J Pharm Sci       Date:  2009-03       Impact factor: 3.534

10.  Parallel monitoring of plasma and intraluminal drug concentrations in man after oral administration of fosamprenavir in the fasted and fed state.

Authors:  Joachim Brouwers; Jan Tack; Patrick Augustijns
Journal:  Pharm Res       Date:  2007-04-19       Impact factor: 4.200

View more
  19 in total

1.  Elucidating the role of dose in the biopharmaceutics classification of drugs: the concepts of critical dose, effective in vivo solubility, and dose-dependent BCS.

Authors:  Georgia Charkoftaki; Aristides Dokoumetzidis; Georgia Valsami; Panos Macheras
Journal:  Pharm Res       Date:  2012-07-04       Impact factor: 4.200

Review 2.  Impact of excipient interactions on drug bioavailability from solid dosage forms.

Authors:  Ravikiran Panakanti; Ajit S Narang
Journal:  Pharm Res       Date:  2012-05-19       Impact factor: 4.200

3.  Biorelevant media to simulate fluids in the ascending colon of humans and their usefulness in predicting intracolonic drug solubility.

Authors:  Maria Vertzoni; Amalia Diakidou; Manos Chatzilias; Erik Söderlind; Bertil Abrahamsson; Jennifer B Dressman; Christos Reppas
Journal:  Pharm Res       Date:  2010-07-30       Impact factor: 4.200

4.  Precipitation in and supersaturation of contents of the upper small intestine after administration of two weak bases to fasted adults.

Authors:  Dimitrios Psachoulias; Maria Vertzoni; Konstantinos Goumas; Vasilios Kalioras; Stefania Beato; James Butler; Christos Reppas
Journal:  Pharm Res       Date:  2011-06-15       Impact factor: 4.200

5.  A Physiologically Based Pharmacokinetic Model for Pregnant Women to Predict the Pharmacokinetics of Drugs Metabolized Via Several Enzymatic Pathways.

Authors:  André Dallmann; Ibrahim Ince; Katrin Coboeken; Thomas Eissing; Georg Hempel
Journal:  Clin Pharmacokinet       Date:  2018-06       Impact factor: 6.447

Review 6.  Physiological parameters for oral delivery and in vitro testing.

Authors:  Deanna M Mudie; Gordon L Amidon; Gregory E Amidon
Journal:  Mol Pharm       Date:  2010-09-07       Impact factor: 4.939

7.  Predicting intestinal precipitation--a case example for a basic BCS class II drug.

Authors:  Sara Carlert; Anna Pålsson; Gunilla Hanisch; Christian von Corswant; Catarina Nilsson; Lennart Lindfors; Hans Lennernäs; Bertil Abrahamsson
Journal:  Pharm Res       Date:  2010-08-18       Impact factor: 4.200

8.  Prediction of Oral Drug Absorption in Rats from In Vitro Data.

Authors:  Yoshiyuki Akiyama; Naoya Matsumura; Asami Ono; Shun Hayashi; Satoko Funaki; Naomi Tamura; Takahiro Kimoto; Maiko Jiko; Yuka Haruna; Akiko Sarashina; Masahiro Ishida; Kotaro Nishiyama; Masahiro Fushimi; Yukiko Kojima; Takuya Fujita; Kiyohiko Sugano
Journal:  Pharm Res       Date:  2022-02-15       Impact factor: 4.200

9.  Linking the Gastrointestinal Behavior of Ibuprofen with the Systemic Exposure between and within Humans-Part 2: Fed State.

Authors:  Paulo Paixão; Marival Bermejo; Bart Hens; Yasuhiro Tsume; Joseph Dickens; Kerby Shedden; Niloufar Salehi; Mark J Koenigsknecht; Jason R Baker; William L Hasler; Robert Lionberger; Jianghong Fan; Jeffrey Wysocki; Bo Wen; Allen Lee; Ann Frances; Gregory E Amidon; Alex Yu; Gail Benninghoff; Raimar Löbenberg; Arjang Talattof; Duxin Sun; Gordon L Amidon
Journal:  Mol Pharm       Date:  2018-11-12       Impact factor: 4.939

10.  Influence of Physiological Gastrointestinal Surfactant Ratio on the Equilibrium Solubility of BCS Class II Drugs Investigated Using a Four Component Mixture Design.

Authors:  Zhou Zhou; Claire Dunn; Ibrahim Khadra; Clive G Wilson; Gavin W Halbert
Journal:  Mol Pharm       Date:  2017-08-22       Impact factor: 4.939

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.